Skip to main content
hello world

Closing Bell: Eupraxia Pharmaceuticals Inc down on Friday (EPRX)

Automated Summaries - The Globe and Mail - Fri Aug 2, 4:01PM CDT

Today, shares of Eupraxia Pharmaceuticals Inc opened at $3.90 and closed at $3.58. Intraday prices ranged from $3.53 to $3.90.

Share prices dipped -6.53% from the previous day's close of $3.83.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.37% at 5446.68, the Dow Jones Industrial Average closed -1.21% at 40347.97 and the Nasdaq Composite closed -2.30% at 17194.15.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

Trading volume was 15,620 on 48 total trades. On average, Eupraxia Pharmaceuticals Inc has traded 18,155 shares in the last five days and 37,843 year-to-date.

The TSX overall saw 741 price advancers against 4,512 declines and 69 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $8.46 (August 15,2023) and low as $3.25 (July 05,2024). Moreover, the shares have shrunken -52.27 percent in the last 52 weeks, while in 2024, they have shrunken -33.33%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $136.43 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.20.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Eupraxia Pharmaceuticals Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..